aluates Reports

$ 0.0

Automative

Global Premature Ejaculation Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-17N9301

Global Premature Ejaculation Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Premature Ejaculation Treatment Market Research Report 2025

Code: QYRE-Auto-17N9301

Report

March 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

GlaxoSmithKline PLC

Bayer

Menarini

Pfizer Inc

Novartis

Eli Lilly

TEVA

Sunrise Pharma

Regent Pacific

Torrent Pharma

VIVUS

Premature Ejaculation Treatment Market Size

The global market for Premature Ejaculation Treatment was valued at US$ 3411 million in the year 2024 and is projected to reach a revised size of US$ 6262 million by 2031, growing at a CAGR of 9.2% during the forecast period.

Premature Ejaculation Treatment Market

Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.

Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.

This report aims to provide a comprehensive presentation of the global market for Premature Ejaculation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premature Ejaculation Treatment.

The Premature Ejaculation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Premature Ejaculation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Premature Ejaculation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Market Segmentation

Scope of Premature Ejaculation Treatment Market Report

Report Metric	Details
Report Name	Premature Ejaculation Treatment Market
Accounted market size in year	US$ 3411 million
Forecasted market size in 2031	US$ 6262 million
CAGR	9.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antidepressants(SSRIs) Phosphodiesterase-5 Inhibitors Topical Anesthetics Analgesics Other Treatment
Segment by Distribution Channel	Hospital Retail Pharmacy Online Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, Bayer, Menarini, Teva, Sunrise Pharma, Regent Pacific, Torrent Pharma, Vivus
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Premature Ejaculation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Premature Ejaculation Treatment Market growing?

Ans: The Premature Ejaculation Treatment Market witnessing a CAGR of 9.2% during the forecast period 2025-2031.

What is the Premature Ejaculation Treatment Market size in 2031?

Ans: The Premature Ejaculation Treatment Market size in 2031 will be US$ 6262 million.

Who are the main players in the Premature Ejaculation Treatment Market report?

Ans: The main players in the Premature Ejaculation Treatment Market are Pfizer, Novartis, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, Bayer, Menarini, Teva, Sunrise Pharma, Regent Pacific, Torrent Pharma, Vivus

What are the Type segmentation covered in the Premature Ejaculation Treatment Market report?

Ans: The Types covered in the Premature Ejaculation Treatment Market report are Antidepressants(SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antidepressants(SSRIs)

1.2.3 Phosphodiesterase-5 Inhibitors

1.2.4 Topical Anesthetics

1.2.5 Analgesics

1.2.6 Other Treatment

1.3 Market by Distribution Channel

1.3.1 Global Premature Ejaculation Treatment Market Growth by Distribution Channel: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Premature Ejaculation Treatment Market Perspective (2020-2031)

2.2 Global Premature Ejaculation Treatment Growth Trends by Region

2.2.1 Global Premature Ejaculation Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Premature Ejaculation Treatment Historic Market Size by Region (2020-2025)

2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Region (2026-2031)

2.3 Premature Ejaculation Treatment Market Dynamics

2.3.1 Premature Ejaculation Treatment Industry Trends

2.3.2 Premature Ejaculation Treatment Market Drivers

2.3.3 Premature Ejaculation Treatment Market Challenges

2.3.4 Premature Ejaculation Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Premature Ejaculation Treatment Players by Revenue

3.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2020-2025)

3.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Premature Ejaculation Treatment Revenue

3.4 Global Premature Ejaculation Treatment Market Concentration Ratio

3.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Premature Ejaculation Treatment Revenue in 2024

3.5 Global Key Players of Premature Ejaculation Treatment Head office and Area Served

3.6 Global Key Players of Premature Ejaculation Treatment, Product and Application

3.7 Global Key Players of Premature Ejaculation Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Premature Ejaculation Treatment Breakdown Data by Type

4.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2020-2025)

4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2026-2031)

5 Premature Ejaculation Treatment Breakdown Data by Distribution Channel

5.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2020-2025)

5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2026-2031)

6 North America

6.1 North America Premature Ejaculation Treatment Market Size (2020-2031)

6.2 North America Premature Ejaculation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Premature Ejaculation Treatment Market Size by Country (2020-2025)

6.4 North America Premature Ejaculation Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Premature Ejaculation Treatment Market Size (2020-2031)

7.2 Europe Premature Ejaculation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Premature Ejaculation Treatment Market Size by Country (2020-2025)

7.4 Europe Premature Ejaculation Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2020-2031)

8.2 Asia-Pacific Premature Ejaculation Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Premature Ejaculation Treatment Market Size (2020-2031)

9.2 Latin America Premature Ejaculation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Premature Ejaculation Treatment Market Size by Country (2020-2025)

9.4 Latin America Premature Ejaculation Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2020-2031)

10.2 Middle East & Africa Premature Ejaculation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Premature Ejaculation Treatment Introduction

11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Premature Ejaculation Treatment Introduction

11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction

11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.3.5 Eli Lilly Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction

11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction

11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.5.5 GlaxoSmithKline Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Premature Ejaculation Treatment Introduction

11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.6.5 Bayer Recent Development

11.7 Menarini

11.7.1 Menarini Company Details

11.7.2 Menarini Business Overview

11.7.3 Menarini Premature Ejaculation Treatment Introduction

11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.7.5 Menarini Recent Development

11.8 Teva

11.8.1 Teva Company Details

11.8.2 Teva Business Overview

11.8.3 Teva Premature Ejaculation Treatment Introduction

11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.8.5 Teva Recent Development

11.9 Sunrise Pharma

11.9.1 Sunrise Pharma Company Details

11.9.2 Sunrise Pharma Business Overview

11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction

11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.9.5 Sunrise Pharma Recent Development

11.10 Regent Pacific

11.10.1 Regent Pacific Company Details

11.10.2 Regent Pacific Business Overview

11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction

11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.10.5 Regent Pacific Recent Development

11.11 Torrent Pharma

11.11.1 Torrent Pharma Company Details

11.11.2 Torrent Pharma Business Overview

11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction

11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.11.5 Torrent Pharma Recent Development

11.12 Vivus

11.12.1 Vivus Company Details

11.12.2 Vivus Business Overview

11.12.3 Vivus Premature Ejaculation Treatment Introduction

11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2020-2025)

11.12.5 Vivus Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

GlaxoSmithKline PLC

Bayer

Menarini

Pfizer Inc

Novartis

Eli Lilly

TEVA

Sunrise Pharma

Regent Pacific

Torrent Pharma

VIVUS

List of Tables

Table 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antidepressants(SSRIs)

Table 3. Key Players of Phosphodiesterase-5 Inhibitors

Table 4. Key Players of Topical Anesthetics

Table 5. Key Players of Analgesics

Table 6. Key Players of Other Treatment

Table 7. Global Premature Ejaculation Treatment Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Premature Ejaculation Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Premature Ejaculation Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Premature Ejaculation Treatment Market Share by Region (2020-2025)

Table 11. Global Premature Ejaculation Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Premature Ejaculation Treatment Market Share by Region (2026-2031)

Table 13. Premature Ejaculation Treatment Market Trends

Table 14. Premature Ejaculation Treatment Market Drivers

Table 15. Premature Ejaculation Treatment Market Challenges

Table 16. Premature Ejaculation Treatment Market Restraints

Table 17. Global Premature Ejaculation Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Premature Ejaculation Treatment Market Share by Players (2020-2025)

Table 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2024)

Table 20. Ranking of Global Top Premature Ejaculation Treatment Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Premature Ejaculation Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Premature Ejaculation Treatment, Headquarters and Area Served

Table 23. Global Key Players of Premature Ejaculation Treatment, Product and Application

Table 24. Global Key Players of Premature Ejaculation Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Premature Ejaculation Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Premature Ejaculation Treatment Revenue Market Share by Type (2020-2025)

Table 28. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Premature Ejaculation Treatment Revenue Market Share by Type (2026-2031)

Table 30. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2020-2025) & (US$ Million)

Table 31. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2020-2025)

Table 32. Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2026-2031) & (US$ Million)

Table 33. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2026-2031)

Table 34. North America Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Premature Ejaculation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Premature Ejaculation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Premature Ejaculation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Premature Ejaculation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Premature Ejaculation Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Premature Ejaculation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Premature Ejaculation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Premature Ejaculation Treatment Product

Table 52. Pfizer Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Premature Ejaculation Treatment Product

Table 57. Novartis Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Eli Lilly Company Details

Table 60. Eli Lilly Business Overview

Table 61. Eli Lilly Premature Ejaculation Treatment Product

Table 62. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 63. Eli Lilly Recent Development

Table 64. Johnson & Johnson Company Details

Table 65. Johnson & Johnson Business Overview

Table 66. Johnson & Johnson Premature Ejaculation Treatment Product

Table 67. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 68. Johnson & Johnson Recent Development

Table 69. GlaxoSmithKline Company Details

Table 70. GlaxoSmithKline Business Overview

Table 71. GlaxoSmithKline Premature Ejaculation Treatment Product

Table 72. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 73. GlaxoSmithKline Recent Development

Table 74. Bayer Company Details

Table 75. Bayer Business Overview

Table 76. Bayer Premature Ejaculation Treatment Product

Table 77. Bayer Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 78. Bayer Recent Development

Table 79. Menarini Company Details

Table 80. Menarini Business Overview

Table 81. Menarini Premature Ejaculation Treatment Product

Table 82. Menarini Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 83. Menarini Recent Development

Table 84. Teva Company Details

Table 85. Teva Business Overview

Table 86. Teva Premature Ejaculation Treatment Product

Table 87. Teva Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 88. Teva Recent Development

Table 89. Sunrise Pharma Company Details

Table 90. Sunrise Pharma Business Overview

Table 91. Sunrise Pharma Premature Ejaculation Treatment Product

Table 92. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 93. Sunrise Pharma Recent Development

Table 94. Regent Pacific Company Details

Table 95. Regent Pacific Business Overview

Table 96. Regent Pacific Premature Ejaculation Treatment Product

Table 97. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 98. Regent Pacific Recent Development

Table 99. Torrent Pharma Company Details

Table 100. Torrent Pharma Business Overview

Table 101. Torrent Pharma Premature Ejaculation Treatment Product

Table 102. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 103. Torrent Pharma Recent Development

Table 104. Vivus Company Details

Table 105. Vivus Business Overview

Table 106. Vivus Premature Ejaculation Treatment Product

Table 107. Vivus Revenue in Premature Ejaculation Treatment Business (2020-2025) & (US$ Million)

Table 108. Vivus Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Premature Ejaculation Treatment Picture

Figure 2. Global Premature Ejaculation Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Premature Ejaculation Treatment Market Share by Type: 2024 VS 2031

Figure 4. Antidepressants(SSRIs) Features

Figure 5. Phosphodiesterase-5 Inhibitors Features

Figure 6. Topical Anesthetics Features

Figure 7. Analgesics Features

Figure 8. Other Treatment Features

Figure 9. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2020-2031) & (US$ Million)

Figure 10. Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Retail Pharmacy Case Studies

Figure 13. Online Pharmacy Case Studies

Figure 14. Other Case Studies

Figure 15. Premature Ejaculation Treatment Report Years Considered

Figure 16. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Premature Ejaculation Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Premature Ejaculation Treatment Market Share by Region: 2024 VS 2031

Figure 19. Global Premature Ejaculation Treatment Market Share by Players in 2024

Figure 20. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2024

Figure 22. North America Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Premature Ejaculation Treatment Market Share by Country (2020-2031)

Figure 24. United States Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Premature Ejaculation Treatment Market Share by Country (2020-2031)

Figure 28. Germany Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Premature Ejaculation Treatment Market Share by Region (2020-2031)

Figure 36. China Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Premature Ejaculation Treatment Market Share by Country (2020-2031)

Figure 44. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2020-2031)

Figure 48. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Premature Ejaculation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 55. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 56. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 57. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 58. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 59. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 60. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 61. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 62. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti premature Ejaculation Drug Market Insights Forecast to 2030

Global OAB Treatment Market Research Report 2025

Global Erectile Dysfunction Treatment Market Insights Forecast to 2030

Global Enuresis Treatment Drugs Market Research Report 2024

Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Male Incontinence Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sexual Dysfunction Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preterm Birth Prevention and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Severe Incontinence Products Market Research Report 2024

Male Adult Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sperm Freezing Medium Market Research Report 2025

Global Drugs for Sexual Dysfunction Market Research Report 2024

Global Urinary Incontinence Drug Market Research Report 2025

Global Penile Cancer Treatment Market Insights Forecast to 2030

Global Male Infertility Treatment Market Insights Forecast to 2030

Global Drugs for Enuresis Market Research Report 2025

Global Genitourinary System Treatment Market Research Report 2024

Global Female Urinary Incontinence Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions